NO885166D0 - Ergolinderivater. - Google Patents

Ergolinderivater.

Info

Publication number
NO885166D0
NO885166D0 NO885166A NO885166A NO885166D0 NO 885166 D0 NO885166 D0 NO 885166D0 NO 885166 A NO885166 A NO 885166A NO 885166 A NO885166 A NO 885166A NO 885166 D0 NO885166 D0 NO 885166D0
Authority
NO
Norway
Prior art keywords
ergoline derivatives
ergoline
derivatives
Prior art date
Application number
NO885166A
Other languages
English (en)
Other versions
NO885166L (no
Inventor
Metilde Buonamici
Lorenzo Pegrassi
Alessandro Rossi
Sergio Mantegani
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878727236A external-priority patent/GB8727236D0/en
Priority claimed from GB888822424A external-priority patent/GB8822424D0/en
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NO885166D0 publication Critical patent/NO885166D0/no
Publication of NO885166L publication Critical patent/NO885166L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO88885166A 1987-11-20 1988-11-18 Ergolinderivater. NO885166L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878727236A GB8727236D0 (en) 1987-11-20 1987-11-20 Antiparkinson ergoline derivatives
GB888822424A GB8822424D0 (en) 1988-09-23 1988-09-23 Antiparkinson ergoline derivatives

Publications (2)

Publication Number Publication Date
NO885166D0 true NO885166D0 (no) 1988-11-18
NO885166L NO885166L (no) 1989-05-22

Family

ID=26293081

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88885166A NO885166L (no) 1987-11-20 1988-11-18 Ergolinderivater.

Country Status (20)

Country Link
US (1) US4847253A (no)
EP (1) EP0317269B1 (no)
JP (1) JP2655706B2 (no)
KR (1) KR890007738A (no)
CN (1) CN1033182A (no)
AU (1) AU602268B2 (no)
CA (1) CA1312015C (no)
DE (1) DE3868866D1 (no)
DK (1) DK645788A (no)
ES (1) ES2032570T3 (no)
FI (1) FI885346A (no)
GR (1) GR3004355T3 (no)
HU (1) HU200557B (no)
IE (1) IE61612B1 (no)
IL (1) IL88392A (no)
MY (1) MY103477A (no)
NO (1) NO885166L (no)
NZ (1) NZ227022A (no)
PH (1) PH24515A (no)
PT (1) PT89036B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE204278T1 (de) * 1992-12-24 2001-09-15 Pharmacia & Upjohn Spa Serotoninergische ergolin derivate
DE69426062T2 (de) * 1993-08-18 2001-03-22 Alcon Laboratories, Inc. Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
GB9407637D0 (en) 1994-04-18 1994-06-08 Erba Carlo Spa Serotoninergic abeo-ergoline derivatives
GB9603226D0 (en) * 1996-02-15 1996-04-17 Pharmacia Spa Heterocyclyl-ergoline derivatives
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
PT1426049E (pt) * 2002-12-02 2005-09-30 Sanol Arznei Schwarz Gmbh Administracao iontoforetica de rotigotina para o tratamento da doenca de parkinson
EP1547592A1 (en) * 2003-12-23 2005-06-29 Schwarz Pharma Ag Intranasal formulation of rotigotine
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
GB8501078D0 (en) * 1985-01-16 1985-02-20 Erba Farmitalia Piperazin-1-yl-ergo-line derivatives

Also Published As

Publication number Publication date
NZ227022A (en) 1991-01-29
DK645788A (da) 1989-05-21
AU602268B2 (en) 1990-10-04
AU2568488A (en) 1989-05-25
FI885346A0 (fi) 1988-11-18
CA1312015C (en) 1992-12-29
FI885346A (fi) 1989-05-21
ES2032570T3 (es) 1993-02-16
GR3004355T3 (no) 1993-03-31
IL88392A (en) 1992-01-15
JP2655706B2 (ja) 1997-09-24
DE3868866D1 (de) 1992-04-09
CN1033182A (zh) 1989-05-31
DK645788D0 (da) 1988-11-18
HUT48463A (en) 1989-06-28
KR890007738A (ko) 1989-07-05
US4847253A (en) 1989-07-11
MY103477A (en) 1993-06-30
PH24515A (en) 1990-07-18
EP0317269A2 (en) 1989-05-24
IE883453L (en) 1989-05-20
JPH01153689A (ja) 1989-06-15
NO885166L (no) 1989-05-22
IL88392A0 (en) 1989-06-30
HU200557B (en) 1990-07-28
EP0317269B1 (en) 1992-03-04
PT89036A (pt) 1988-12-01
PT89036B (pt) 1993-02-26
EP0317269A3 (en) 1990-05-16
IE61612B1 (en) 1994-11-16

Similar Documents

Publication Publication Date Title
TR26815A (tr) Azolilmetil-sikropil türevleri
DK295288A (da) (1h-azol-1-ylmethyl)substituerede benzotriazolderivater
NO885166D0 (no) Ergolinderivater.
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188A (da) Cholecalciferolderivater
DE3872153D1 (de) 25-hydroxy-vitamin-d3-derivate.
FI882750A0 (fi) Tricykliska pyridonderivat.
DK378088D0 (da) Alkenderivater
FI883963A (fi) Isoxazol- -karbolinderivat.
DK49688A (da) Propiolophenonderivater
NO884830L (no) Purin-derivater.
FI882277A0 (fi) Nitrogen innehaollande epipodofyllotoxin-glukosid-derivat.
DK271088A (da) Tienopyridinderivater
DE3889644D1 (de) Pheophorbidderivate.
DE3861208D1 (de) Hydroxyalkyl-triazolyl-derivate.
DK695788D0 (da) Naphtalenderivater
DE3866371D1 (de) Diphenylaethylen-derivate.
DK733688D0 (da) Dioxazocinderivater
DK32389A (da) Ergolinderivater.
DE3868364D1 (de) Ucy-1003-derivate.
DE3863447D1 (de) Aminoethylphosphinsaeure-derivate.
DE3884482D1 (de) Thiapentanamid-derivate.
DE3881146D1 (de) Thiazetidin-derivate.
NO892643D0 (no) Substituerte azacykloheksyl-derivater.
FI880533A0 (fi) Tricykliska triazolopyrimidinderivat.